MedTrace Logo

Study to Evaluate Constituents in Exhaled Breath and Room Air From Use of E-vapor Products and Conventional Cigarettes

NCT03605641 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2021-06-14

No results posted yet for this study

Summary

An open-label, single center, three-arm observational study to examine emissions from e-cigarettes versus conventional cigarettes under three environmental settings of typical residential, office and hospitality facilities.

Conditions

  • Second Hand Tobacco Smoke

Interventions

OTHER

JUUL

JUUL Virginia Tobacco

OTHER

VUSE Solo

VUSE SOLO Original

OTHER

Conventional Cigarette

Subject preferred conventional cigarette

Sponsors & Collaborators

  • Inflamax Research Incorporated

    collaborator INDUSTRY

  • Juul Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Peter Couroux, MD · Inflamax Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2018-12-02
Completion
2018-12-02

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03605641 on ClinicalTrials.gov